RTI Health Solutions researcher Matthew Cawson will be presenting research on treatments for acute myeloid leukemia at the upcoming British Society for Haematology Annual Scientific Meeting.
Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemotherapy (daunorubicin and cytarabine) for first-line treatment of acute myeloidleukaemia. Mokgokong R, Mamolo C, Cappelleri J, Knight C, Brockbank J, Cawson M, Dombre H, Castaigne S.
Poster Number: BSH19-PO-015
Location: Halls 1&2 - Exhibition Hall
Viewing: Monday, 1 April
Poster Moderation Session: Tuesday, 2 April, 18:15 - 19:15
If you would like to arrange a meeting with Matthew during the conference, click here.